CEACAM5 and neoplasm: 89Zr-CEA-IL2v blood levels and biodistribution in non-tumor tissues in cycle 1 are presented in Figure 4, showing homogeneous tracer distribution in the circulation at day 2, increasing hepatic and splenic uptake at day 5 and decreasing uptake at day 9, partially due to subsequent excretion.